研报 | 关注财报与美联储态度,美股小幅收跌

wechat omage

美股

北京时间2月27日凌晨,美股周二小幅收跌。家得宝财报欠佳、美国新屋开建数字锐减,令市场情绪承压。美联储主席鲍威尔重申联储的观望立场,称美联储的货币政策仍将取决于经济数据。

截至收盘,道指跌33.97点,或0.13%,报26057.98点;标普500指数跌2.21点,或0.08%,报2793.90点;纳指跌5.16点,或0.07%,报7549.30点。

家得宝的糟糕财报令市场受到打压。该公司宣布第四财季每股收益2.09美元,低于市场平均预期的2.16美元。此外该公司还发布了低于预期的2019年业绩展望。

而美国疲软的房地产行业数据也使美股受挫。美国商务部报告称,美国12月新屋开建数字锐减11.2%,降至2016年9月以来的最低水平。

美联储主席鲍威尔周二在国会参议院银行业委员会发表的证词备受关注。周三他将在国会众议院金融服务委员会面前作证。

鲍威尔出席参议院听证会时表示:“就业市场保持强劲,通胀接近2%。资产负债表的规模将由储备和货币需求推动。如有必要,美联储将调整资产负债表正常化进程。随着经济前景的变化,美联储的政策将取决于经济数据。美联储目前正在评估结束缩表的合适时间以及方式。”

鲍威尔表示,1月FOMC会议认为在未来政策问题上需要保持耐心,美联储资产负债表的规模将取决于储备和货币需求。

鲍威尔认为美国经济前景良好,但也伴随一些逆流。他称联邦政府部分关门带来的负面影响较小,但联邦政府的财政路径不可持续。

宏观基本面:

美国商务部周二报告称,12月房屋开建数量环比减少11.2%,经季节调整年率为108万户。这是自2016年9月以来建设速度最慢的一次。作为未来经济活动指标的新屋开建许可12月份仅增长0.3%。

美国去年12月新建住宅数量跌至两年多来的最低水平,这可能表明开发商预计今年新屋销售将减少。

焦点股关注:

房屋装修用品零售巨头家得宝(HD)股价走低,该公司周二盘前公布的季度业绩低于预期。此外,该公司董事会批准了150亿美元的股票回购计划。

特斯拉(TSLA)受到关注。该公司CEO埃隆-马斯克(Elon Musk)就其最近在推特上发表的言论与美国证券交易委员会(SEC)发生冲突。SEC周一要求一名联邦法官认定马斯克藐视违反协议。

卡特彼勒(CAT)股价走低,此前瑞银(12.61, 0.15, 1.20%)将其股票评级下调为卖出。

 

   

港股

北京时间2月25日,美股周一收高。贸易谈判取得进展的迹象以及并购交易消息提振了市场情绪。周二开盘,港股恒生指数高开0.04%,随后跳水在28820点上下震荡。

截至收盘,恒生指数跌0.65%,报28772.06点;国企指数跌0.75%,报11543.95点;红筹指数跌0.65%,报4530.12点。

沪港通资金流向方面,沪股通净流入10.11亿,港股通(沪)净流出为25.8亿。

深港通资金流向方面,深股通净流入13.19亿,港股通(深)净流入为405万。

热点板块:

中资券商股下跌。中州证券跌11.19%;中国银河跌5.05%;华泰证券跌5.86%。

苹果概念股下跌。瑞声科技首季溢利预跌65%-75%,股价跌14.04%,报50.5港元,领跌蓝筹。瑞声科技发盈警,预计3月止第一季度股东应占综合溢利将下跌至2.8-3.9亿人民币,按年跌幅介乎65%-75%。声明指,除第一季度通常是较弱的季度外,同时受客户订单下降所致,公司第一季度收入预计将受到明显的负面影响。正处于转型期的产品组合以及生产数量的减少亦将对季度毛利率乃至净利润带来不利影响。此外,高伟电子跌5.63%;比亚迪电子跌4.79%。

复星医药AH股持续上涨,A股涨6.73%,H股涨7.42%。公司昨晚公告,国家药品监督管理局网站发布新闻:2月22日,国家药品监督管理局批准公司控股子公司上海复宏汉霖生物制药有限公司研制的利妥昔单抗注射液(商品名:汉利康)上市注册申请;该药是国内获批的首个生物类似药,主要用于非霍奇金淋巴瘤的治疗。复星医药还表示,截至公告日,该新药的《药品注册批件》尚待取得。此外,该新药在进行商业化生产前,尚需取得GMP认证证书。

基石药业周二在香港挂牌,股价大涨7.17%,报12.86港元。据辉立交易场资料显示,暗盘收报13.00港元,较招股价12.00港元,涨8.333%。每手500股,不计手续费,每手赚500港元。
 

 

中国A股

北京时间2月26日,周二两市集体高开,沪指随后宽幅震荡,午后盘中一度逼近3000点,深成指走势与沪指基本一致,尾盘回落。全天成交额再度突破万亿大关,达10977亿元,上一交易日为10406亿元。

截至收盘,沪指收报2941.52点,跌0.67%,成交额4924亿。深成指收报9089.04点,跌0.50%,成交额6053亿。

从盘面上看,养鸡、高送转、钢铁、猪肉、煤炭、生物制品、港口航运等板块涨幅居前,银行、白酒、柔性屏等板块小幅飘绿。

热点板块:

钢铁股午后表现活跃,包钢股份、沙钢股份涨停,西宁特钢、酒钢宏兴涨超9%,八一钢铁)、山东钢铁、河钢股份、永兴特钢涨超6%。

高送转概念股全天表现活跃,联创互联、三鑫医疗、正元智慧、金奥博、川环科技、兴瑞科技、扬帆新材等超10股涨停。
 

如果有想了解更多全球股市资讯,请关注微信公众共 “辉立资本新加坡” (SGPSPL)

同时提供在线免费开设股票账户,一个账户轻松交易美股,港股,新加坡股
 

来源:东方财富网,新浪财经,同花顺,21世纪经济报道,彭博,华尔街见闻,辉立证券

联系我们开设账户

需要帮助吗?请分享您的详细资料,我们会给您答复。

IMPORTANT INFORMATION

This material is provided by Phillip Capital Management (S) Ltd (“PCM”) for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in any of the exchange-traded fund (“ETF”) or the unit trust (“Products”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for key features, key risks and other important information of the Products and obtain advice from a financial adviser (“FA“) pursuant to a separate engagement before making a commitment to invest in the Products. In the event that you choose not to obtain advice from a FA, you should assess whether the Products are suitable for you before proceeding to invest. A copy of the Prospectus and PHS are available from PCM, any of its Participating Dealers (“PDs“) for the ETF, or any of its authorised distributors for the unit trust managed by PCM.  

An ETF is not like a typical unit trust as the units of the ETF (the “Units“) are to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its NAV or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Investors cannot create or redeem Units directly with PCM and have no rights to request PCM to redeem or purchase their Units. Creation and redemption of Units are through PDs if investors are clients of the PDs, who have no obligation to agree to create or redeem Units on behalf of any investor and may impose terms and conditions in connection with such creation or redemption orders. Please refer to the Prospectus of the ETF for more details.  

Investments are subject to investment risks including the possible loss of the principal amount invested. The purchase of a unit in a fund is not the same as placing your money on deposit with a bank or deposit-taking company. There is no guarantee as to the amount of capital invested or return received. The value of the units and the income accruing to the units may fall or rise. Past performance is not necessarily indicative of the future or likely performance of the Products. There can be no assurance that investment objectives will be achieved.  

Where applicable, fund(s) may invest in financial derivatives and/or participate in securities lending and repurchase transactions for the purpose of hedging and/or efficient portfolio management, subject to the relevant regulatory requirements. PCM reserves the discretion to determine if currency exposure should be hedged actively, passively or not at all, in the best interest of the Products.  

The regular dividend distributions, out of either income and/or capital, are not guaranteed and subject to PCM’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value (“NAV”) of the Products. Please refer to <www.phillipfunds.com> for more information in relation to the dividend distributions.  

The information provided herein may be obtained or compiled from public and/or third party sources that PCM has no reason to believe are unreliable. Any opinion or view herein is an expression of belief of the individual author or the indicated source (as applicable) only. PCM makes no representation or warranty that such information is accurate, complete, verified or should be relied upon as such. The information does not constitute, and should not be used as a substitute for tax, legal or investment advice.  

The information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PCM to any registration or licensing requirement in such jurisdiction or country. The Products is not offered to U.S. Persons. PhillipCapital Group of Companies, including PCM, their affiliates and/or their officers, directors and/or employees may own or have positions in the Products. Any member of the PhillipCapital Group of Companies may have acted upon or used the information, analyses and opinions herein before they have been published. 

This advertisement has not been reviewed by the Monetary Authority of Singapore.  

 

Phillip Capital Management (S) Ltd (Co. Reg. No. 199905233W)  
250 North Bridge Road #06-00, Raffles City Tower ,Singapore 179101 
Tel: (65) 6230 8133 Fax: (65) 65383066 www.phillipfunds.com